The Telomerase Assay evolved from research performed at the University of Maryland, Baltimore Medical Center by a team under the direction of Dr. Edward Highsmith. The funding will support the gathering of clinical data on the Telomerase Assay. Lung cancer is the leading cause of cancer deaths worldwide. Dr. Siamak Tabibzadeh is developing the test at North Shore University Hospital in Manhasset, New York. Lexon recently announced the production and successful characterization of a polyclonal antibody to the ebaf protein.
Colon cancer is the second leading cause of cancer deaths.
The opinions expressed here reflect our judgement at the date and are subject to change. The information has been obtained from sources we consider to be reliable but we cannot guarantee its accuracy. Our company, its officers, employees or customers may have positions in the securities mentioned.